Clinical Trials Directory

Trials / Unknown

UnknownNCT06044415

Brain Activity Under the Influence of JWH

Brain Kinetics of Neurotransmission During JWH-018 Intoxication

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Maastricht University · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The goal of this placebo-controlled study is to learn about the neural mechanisms underlying the acute effects of the synthetical cannabinoid JWH-018 in healthy, occasional cannabis users. It aims to assess neural underpinnings of neurocognitive impairments and psychotomimetic symptoms expected during the intoxication. Neuronal changes similar to those seen in cannabis intoxication are expected, such as altered neurotransmission and loss of functional connectivity within the mesocorticolimbic circuit. MRS, fMRI and blood parameters will be used for assessment. Participants will be asked to complete cognitive tasks and subjective questionnaires related to the subjective experience of the drug.

Conditions

Interventions

TypeNameDescription
DRUGJWH018A vaporized dose of 7.5 mg of JWH-018 will be inhaled by the participants
OTHERnon-active control (no substance)Participants will inhale from a vaporizer with an empty chamber.

Timeline

Start date
2023-10-01
Primary completion
2024-10-01
Completion
2024-10-01
First posted
2023-09-21
Last updated
2023-09-21

Source: ClinicalTrials.gov record NCT06044415. Inclusion in this directory is not an endorsement.